Back
Bumble Vs. Kymera Therapeutics Industry Stock Comparison
Buy
53
BMBL
Bumble
Last Price:
$6.46
Seasonality Move:
-24.64%
Buy
72
KYMR
Kymera Therapeutics
Last Price:
$43.97
Seasonality Move:
20.91%
Buy
72
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.71. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMBL Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.71The current trend is moderately bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMBL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 71.46 | Buy |
Chaikin Money Flow: | -3823110 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.08 - 5.94) | Buy |
Bollinger Bands (100): | (4.11 - 6.69) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.26 | Buy |
Relative Strength Index (14 RSI): | 63.42 | Buy |
Chaikin Money Flow: | 778150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34 - 49.4) | Buy |
Bollinger Bands (100): | (27.24 - 41.26) | Buy |
BMBL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.53 | Buy |
20-day SMA: | 5.43 | Buy |
50-day SMA: | 5.19 | Buy |
200-day SMA: | 6.44 | Buy |
8-day EMA: | 5.71 | Buy |
20-day EMA: | 5.5 | Buy |
50-day EMA: | 5.36 | Buy |
200-day EMA: | 6.64 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.39 | Sell |
20-day SMA: | 44.78 | Buy |
50-day SMA: | 36.22 | Buy |
200-day SMA: | 39.59 | Buy |
8-day EMA: | 46.24 | Sell |
20-day EMA: | 43.8 | Buy |
50-day EMA: | 38.8 | Buy |
200-day EMA: | 37.28 | Buy |
Bumble Earnings Growth & BMBL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.88 per share, and an increase next year of $0.05 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.47 per share.
Bumble Technical Analysis
Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |